Tirofiban counteracts endothelial cell apoptosis through the VEGF/VEGFR2/pAkt axis. (scientific article)

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

Q22004269

Crystal structure of the extracellular segment of integrin alpha Vbeta3

Q24291661

Structure and function of the platelet integrin alphaIIbbeta3

Q24536159

Integrins: bidirectional, allosteric signaling machines

Q27860700

Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors

Q28236317

TNFα induces survival through the FLIP-L-dependent activation of the MAPK/ERK pathway

Q28580836

RGD and other recognition sequences for integrins

Q29616331

Signalling pathways of the TNF superfamily: a double-edged sword

Q29616428

VEGF receptor signalling - in control of vascular function

Q29617256

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

Q29618717

Requirement of vascular integrin alpha v beta 3 for angiogenesis

Q29619681

PI3K inhibitors for cancer treatment: where do we stand?

Q34921551

Integrin αIIbβ3: from discovery to efficacious therapeutic target

Q37011736

PTEN-regulated AKT/FoxO3a/Bim signaling contributes to reactive oxygen species-mediated apoptosis in selenite-treated colorectal cancer cells.

Q37073648

Abciximab, eptifibatide, and tirofiban exhibit dose-dependent potencies to dissolve platelet aggregates

Q40661372

RGD peptides induce apoptosis by direct caspase-3 activation.

Q40971438

Effects of ligand-mimetic peptides Arg-Gly-Asp-X (X = Phe, Trp, Ser) on alphaIIbbeta3 integrin conformation and oligomerization

Q42612916

The GPIIbIIIa antagonist drugs eptifibatide and tirofiban do not induce activation of apoptosis executioner caspase-3 in resting platelets but inhibit caspase-3 activation in platelets stimulated with thrombin or calcium ionophore A23187.

Q42956330

Increased concentrations of tirofiban in blood and their correlation with inhibition of platelet aggregation after greater bolus doses of tirofiban

Q44301237

In vivo induction of endothelial apoptosis leads to vessel thrombosis and endothelial denudation: a clue to the understanding of the mechanisms of thrombotic plaque erosion

Q44899711

Tirofiban induces VEGF production and stimulates migration and proliferation of endothelial cells.

Q53056524

Immunomodulatory pathways regulate expression of a spliced FKBP51 isoform in lymphocytes of melanoma patients.

Q53536244

Atorvastatin sensitises vascular smooth muscle cells, but not endothelial cells, to TNF-α-induced cell death.

Q54475719

Effect of anti-tumor necrosis factor-α polyclonal antibody on restenosis after balloon angioplasty in a rabbit atherosclerotic model

Q56944543

Glycoprotein IIb/IIIa antagonists induce apoptosis in rat cardiomyocytes by caspase-3 activation

Q73462995

Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies

Q79370601

P304

page(s)

67-74

P577

publication date

2015-12-15

P1433

published in

Vascular Pharmacology

Q7916446

P1476

title

Tirofiban counteracts endothelial cell apoptosis through the VEGF/VEGFR2/pAkt axis.

P478

volume

Reverse relations

cites work (P2860)

Q93140384	Astragaloside IV inhibits oxidized low‑density lipoprotein‑induced endothelial damage via upregulation of miR‑140‑3p
Q33842838	Novel small peptides derived from VEGF125-136: potential drugs for radioactive diagnosis and therapy in A549 tumor-bearing nude mice
Q37412613	Platelet Integrin αIIbβ3 Inhibitor Rescues Progression of Apoptosis in Human Platelets
Q90470411	The splicing FK506-binding protein-51 isoform plays a role in glioblastoma resistance through programmed cell death ligand-1 expression regulation

P356	DOI	10.1016/J.VPH.2015.12.001
P698	PubMed publication ID	26699078